HeartBeam (Nasdaq:BEAT) announced today that it entered into a strategic collaboration with the Icahn School of Medicine at Mount Sinai.
A new national survey found that while many Americans use a device to monitor their heart, few share that data with their doctor. Advances in technology have made it increasingly easier for people to ...
The Food and Drug Administration awarded approval to CardioMEMS Hero, a new version of the device that patients use to take daily pulmonary artery pressure readings. Abbott has made Hero smaller and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results